ROCKVILLE, Md., June 13, 2013 /PRNewswire/ -- RRD International, a product development company that provides expert-level strategic, regulatory and operational support to biopharmaceutical companies and investors, announced today the appointment of J. Scott Tarrant as its President. Mr. Tarrant joined RRD in 2010 as Chief Business Officer and has been responsible for shepherding the company's strategic growth initiatives.
"Scott has played a pivotal role in the company's growth and development," said Charles (Chuck) Finn, PhD, CEO and Co-Founder of RRD International. "Not only has Scott been responsible for developing our go-forward strategy, he has helped align internal practices and models to drive marketplace adoption. His insight and understanding as to the state of change within the life science industry, together with his development knowledge make him the ideal person to run RRD day-to-day."
While day-to-day operational responsibilities will be transferred to Mr. Tarrant, Dr. Finn will remain actively engaged in determining the strategic direction of the company and providing high-level support to our partners. "Scott's promotion will enable me to focus fully on the strategic and scientific needs of our clients' development programs. This transition also enables the most effective use of our internal resources to the benefit of our clients and the Company," added Finn.
"Since RRD was founded in 2002, it has been evolving to meet industry needs and this transition represents another chapter of our growth," said Frank Hurley, Chairman of the Board, CSO and Co-Founder, RRD International. "When Symphony Capital needed world-class product development capabilities to support its 400 million dollar investment in pipeline programs, they chose RRD to maximize opportunity of each drug candida
|SOURCE RRD International|
Copyright©2012 PR Newswire.
All rights reserved